🔗 Share this article TikTok Content Creators Driving Unofficial Market for Unapproved Slimming Medication An underground market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings. Experimental Treatment Gaining Traction Online Retatrutide, which is still in research studies, is being advertised by online personalities for its supposed fat-burning effects. Followers are urged to contact these accounts privately for source information, while also obtaining promotional offers. Active Trade on Messaging Platforms Separately, a robust trade exists on messaging services, where communities with thousands of members share comparison photos, injection guides and assertions of next-day British shipping. Vendors market the substance there before directing buyers to other platforms for purchases. Understanding The Experimental Drug Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic. Healthcare Experts Voice Concerns Nevertheless, doctors and chemists have warned that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could lead to individuals injecting products of unknown origin. Several experts stated the popularity for the experimental drug could be connected to the increasing cost of licensed slimming products such as Mounjaro. Legal Position and Implementation Marketing the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012. Several content creators try to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still violate pharmaceutical, advertising, and customer laws, potentially leading to fines, prosecution or prison. Service Response and Material Elimination According to the social media company, the platform has removed problematic content and banned related hashtags and search suggestions. The company said it was committed to maintaining the platform safe and allocating resources in enhancing compliance measures. Digital Marketplace Activities Investigations also found communities with up to nine thousand members selling the experimental drug using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” immediately displays channels with thousands of users, filled with images of slimming results, positive reviews and detailed instructions for preparing or administering at home. After moments of joining one community, a seller posted WhatsApp details, where most transactions occur. The seller provided an guidebook and guaranteed shipping within two days. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one asked about weight, health issues or past usage. Product Information and Costs Within these groups, posts show black plastic packages with postal service labels, stating to contain new batches. One communication read: “It took eight of us to load them this morning.” Customers can select between powder vials, prepared at home with purified liquid, or pre-filled pens usually sold at £160 for 20mg. When asked how long a pen should last, sellers give conflicting responses varying between a few weeks to “depends on your body”. Service Oversight and Safety Measures A representative for Telegram stated it actively monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”. Healthcare Expert Warnings “Individuals are injecting substances they can’t verify. Even if the science behind retatrutide is sound, these online products may not contain what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U. Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent price rises for approved slimming medications such as Mounjaro. “With prices rising, individuals are turning to social media. But fake injections are highly dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she said. Her team has already encountered individuals harmed by self-injection from unverified suppliers. “We understand the disappointment, but buying from Telegram or communication platforms is gambling with your health,” stated the doctor. “These substances could be contaminated or incorrectly dosed.” Manufacturer Position A spokesperson from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company experimental substance not yet approved … may subject patients to possibly significant medical dangers”.